JL
Jayesh Laljibhai Kanjaria
About Jayesh Laljibhai Kanjaria
Data last updated:
Jayesh Laljibhai Kanjaria is a Director at Supravida Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supravida Pharmaceuticals Private Limited U47721GJ2025PTC160269 | Director | 13 Mar 2025 | 2025 | Active |
Board colleagues of Jayesh Laljibhai Kanjaria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavin Dhirajlal Savaliya | 07814469 | Supravida Pharmaceuticals Private Limited | Director |
| Kamlesh Dosabhai Gojiya | 09433025 | Supravida Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayesh Laljibhai Kanjaria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayesh Laljibhai Kanjaria
Jayesh Laljibhai Kanjaria currently holds 1 directorship: Supravida Pharmaceuticals Private Limited (Director, since 13 Mar 2025).
Jayesh Laljibhai Kanjaria was first appointed on 13 Mar 2025 as Director at Supravida Pharmaceuticals Private Limited.
The current boards of Jayesh Laljibhai Kanjaria's companies include Bhavin Dhirajlal Savaliya (Supravida Pharmaceuticals Private Limited), Kamlesh Dosabhai Gojiya (Supravida Pharmaceuticals Private Limited).